These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E. J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489 [Abstract] [Full Text] [Related]
6. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy. Brazionis L, Rowley K, Jenkins A, Itsiopoulos C, O'Dea K. Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151 [Abstract] [Full Text] [Related]
7. Hypertension and related risk factors in type 2 diabetes mellitus. Lunetta M, Barbagallo A, Crimi S, Di Mauro M, Sangiorgio L, Mughini L. Minerva Endocrinol; 1999 Jun; 24(2):45-50. PubMed ID: 10941422 [Abstract] [Full Text] [Related]
8. Association of elevated serum uric acid with coronary heart disease in diabetes mellitus. Rathmann W, Hauner H, Dannehl K, Gries FA. Diabete Metab; 1993 Jun; 19(1 Pt 2):159-66. PubMed ID: 8314420 [Abstract] [Full Text] [Related]
12. Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Zumbach M, Hofmann M, Borcea V, Luther T, Kotzsch M, Müller M, Hergesell O, Andrassy K, Ritz E, Ziegler R, Wahl P, Nawroth PP. Exp Clin Endocrinol Diabetes; 1997 Jun; 105(4):206-12. PubMed ID: 9285207 [Abstract] [Full Text] [Related]
13. Serum adiponectin is associated with fasting serum C-peptide in non-obese diabetic patients. Furuta M, Tamai M, Hanabusa T, Yamamoto Y, Nanjo K, Sanke T. Diabetes Res Clin Pract; 2006 Jun; 72(3):302-7. PubMed ID: 16442181 [Abstract] [Full Text] [Related]
14. Platelet protein kinase C isoform content in type 2 diabetes complicated with retinopathy and nephropathy. Kimura M, Ishizawa M, Miura A, Itaya S, Kanoh Y, Yasuda K, Uno Y, Morita H, Ishizuka T. Platelets; 2001 May; 12(3):138-43. PubMed ID: 11304414 [Abstract] [Full Text] [Related]
15. Variation of fasting serum C-peptide level after admission in Japanese patients with type 2 diabetes mellitus. Tajiri Y, Kimura M, Mimura K, Umeda F. Diabetes Technol Ther; 2009 Sep; 11(9):593-9. PubMed ID: 19764839 [Abstract] [Full Text] [Related]
16. Microangiopathy and visual deficits characterize the retinopathy of a spontaneously hypertensive rat model with type 2 diabetes and metabolic syndrome. Huber M, Heiduschka P, Ziemssen F, Bolbrinker J, Kreutz R. Hypertens Res; 2011 Jan; 34(1):103-12. PubMed ID: 20927114 [Abstract] [Full Text] [Related]
18. Adiponectin and sE-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease. El-Mesallamy HO, Hamdy NM, Salman TM, Ibrahim SM. Angiology; 2012 Feb; 63(2):96-102. PubMed ID: 21602254 [Abstract] [Full Text] [Related]
19. Mortality from coronary heart disease and cerebrovascular disease and associated risk factors in diabetic patients in Osaka District, Japan. Sasaki A, Horiuchi N, Hasegawa K, Uehara M. Diabetes Res Clin Pract; 1995 Jan; 27(1):77-83. PubMed ID: 7781497 [Abstract] [Full Text] [Related]
20. C-peptide and chronic complications in patients with type-2 diabetes and the metabolic syndrome. Mavrakanas T, Frachebois C, Soualah A, Aloui F, Julier I, Bastide D. Presse Med; 2009 Oct; 38(10):1399-403. PubMed ID: 19419831 [Abstract] [Full Text] [Related] Page: [Next] [New Search]